High Outlier
Strength
200 mg/1
Manufacturer
Janssen Products LPNDC
59676057101
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ETRAVIRINEApproval Type
New Drug (NDA)
FDA Application
NDA022187On Market Since
12/22/2010
Pharmacological Classes
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors
Related Drugs
Same classification
NEXIUM 24HR 22.3 MG CAPSULE
Brand
00573245014•Haleon US Holdings LLC
$0.5906
per EA
NEXIUM 24HR 22.3 MG CAPSULE
Brand
00573245028•Haleon US Holdings LLC
$0.5906
per EA
NEXIUM 24HR 22.3 MG CAPSULE
Brand
00573245042•Haleon US Holdings LLC
$0.5906
per EA
NEXIUM 24HR 22.3 MG CAPSULE
Brand
00573245043•Haleon US Holdings LLC
$0.5906
per EA
PRILOSEC OTC 20.6 MG TABLET
Brand
37000045502•The Procter & Gamble Manufacturing Company
$0.6120
per EA
PRILOSEC OTC 20.6 MG TABLET
Brand
37000045503•The Procter & Gamble Manufacturing Company
$0.6120
per EA
PRILOSEC OTC 20.6 MG TABLET
Brand
37000045504•The Procter & Gamble Manufacturing Company
$0.6120
per EA
PRILOSEC OTC 20.6 MG TABLET
Brand
37000045902•The Procter & Gamble Manufacturing Company
$0.6120
per EA
PRILOSEC OTC 20.6 MG TABLET
Brand
37000045904•The Procter & Gamble Manufacturing Company
$0.6120
per EA
EPRONTIA 25 MG/ML SOLUTION
Brand
52652900101•Azurity Pharmaceuticals Inc.
$1.6041
per ML